Abstract:Aβ is a product derived from sequential proteolytic cleavage of β–amyloid precursor protein (APP) by β–and γ–secretases, while cleavage of APP by α–and γ–secretases does not yield Aβ. Since β–and γ–secretases are located in cholesterol–rich lipid rafts of cell membrane and α–secretase is located in phospholipid–rich domains of cell membrane, the activities of these secretases and APP processing may be subject to the changes of cholesterol or/and phospholipids in cellular membrane. A group of ATP–binding cassette (ABC) transporters are known to transport and regulate cholesterol and phospholipids in cells, such as ABCA1, ABCG1 and ABCG4. These transporters can mediate efflux of cholesterol and phospholipids from cell membrane to high–density lipoproteins (HDL). ABCG1 and ABCG4 are primarily expressed in the brain and can form homodimer or heterodimer to function. We have studied the roles of ABCG1/ABCG4 and cholesterol in the regulation of β–and γ–secretase activities for Aβ production and demonstrated that: 1) Cholesterol assays revealed that the level of cholesterol was significantly higher in AD than in age–matched non–demented (ND) control brain samples. 2) In vitro assays demonstrated that the activities of β–and γ–secretases were significantly higher in AD than in ND brain samples, which correspond to higher levels of cholesterol and Aβ deposition in AD brain samples. 3) ABCG1 and ABCG4 are highly expressed in normal human brain samples. However, real–time Q–PCR and Western blots showed that ABCG1 and ABCG4 were down–regulated at the protein and mRNA levels, respectively, in AD compared to ND brain samples. 4) Human ABCG1 and ABCG4 genes were cloned and their overexpression in neuroblastoma N2a cells–transfected with APP increased cellular cholesterol efflux to HDL by cholesterol efflux assays and significantly decreased cellular cholesterol levels compared to empty vector–transfected cells. 5) Reduced cellular cholesterol mediated by ABCG1/ABCG4 efflux significantly decreased β–and γ–secretase activities and Aβ production in N2a cells. These results suggest that higher cholesterol levels correlate well with higher β–and γ–secretase activities and Aβ deposition in AD compared to ND brain samples and that ABCG1/ABCG4–mediated cholesterol efflux to HDL is an important factor affecting cellular cholesterol that regulates β–and γ–secretase activities for Aβ production.

Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs

Altered brain arginine metabolism with age in the APPswe/PSEN1dE9 mouse model of Alzheimer's disease

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Aging reduces glial uptake and promotes extracellular accumulation of AÎ² from a lentiviral vector

Non‐transgenic guinea pig strains exhibit divergent age‐related changes in hippocampal mitochondrial respiration

Aging reduces glial uptake and promotes extracellular accumulation of Aβ from a lentiviral vector.

Cholesterol retention in Alzheimer's brain is responsible for high β-and γ-secretase activities and Aβ production

P4–057: ABCG1/ABCG4–mediated Cellular Cholesterol Efflux Affects Β–and Γ–secretase Activities and Β–amyloid Production in N2a Cells

Analysis of Serum Β-Amyloid Peptides, Α2-Macroglobulin, Complement Factor H, and Clusterin Levels in APP/PS1 Transgenic Mice During Progression of Alzheimer's Disease.

Progressive Spatial Memory Impairment, Brain Amyloid Deposition And Changes In Serum Amyloid Levels As A Function Of Age In Appswe/Ps1de9 Mice

Age-Dependent and Aβ-Induced Dynamic Changes in the Subcellular Localization of HMGB1 in Neurons and Microglia in the Brains of an Animal Model of Alzheimer's Disease

Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human

Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease

Dynamic changes in lysosome-related pathways in APP/PS1 mice with aging

Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin

Higher Serum Total Cholesterol Levels in Late Middle Age Are Associated with Glucose Hypometabolism in Brain Regions Affected by Alzheimer'S Disease and Normal Aging

The Relationship among Amyloid-Β Deposition, Sphingomyelin Level, and the Expression and Function of P-glycoprotein in Alzheimer’s Disease Pathological Process

Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms

Pgc-1 Alpha Expression Decreases In The Alzheimer Disease Brain As A Function Of Dementia

O1–08–02: Cathepsin B Produces Brain Pyro‐glu‐beta‐amyloid in a Transgenic Alzheimer's Disease Mouse Model

Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APP swe Transgenic Mice